Pharmaceutical and Biotechnology Market Size, Share, By Product (Biotechnology and Pharmaceutical), Age Group (Children & Adolescents, Adults, and Geriatric), Technology (Nanotechnology, Tissue Engineering & Regeneration, PCR & Sequencing, Artificial Inte
Description
Pharmaceutical and Biotechnology Market Size, Share, By Product (Biotechnology and Pharmaceutical), Age Group (Children & Adolescents, Adults, and Geriatric), Technology (Nanotechnology, Tissue Engineering & Regeneration, PCR & Sequencing, Artificial Intelligence (AI), Personalized Medicine, and Others), Therapeutic Application (Oncology, Inflammatory and Infectious Diseases, Autoimmune Disorders, Metabolic Disorders, Hormonal Disorders, Disease Prevention, Cardiovascular Diseases, Neurological Diseases and Others), End User (Pharmaceutical Companies, Biotechnology Companies, Healthcare Providers, Research and Government Institutes, and Others), and Region - Trends, Analysis and Forecast till 2035
The Pharmaceutical and Biotechnology Market Report offers an in-depth exploration of emerging market trends, driving factors, challenges, and key segments that shape the industry. It includes a thorough examination of regulatory frameworks, company profiles, and the latest industry developments. The report delves into product development, positioning strategies, and the impact of new technologies on the market landscape. By identifying challenges and opportunities, the report provides a detailed roadmap for market growth.
Pharmaceuticals are medicinal drugs, while biotechnology is the use of biological research to develop products from living organisms. Pharmaceuticals and biotechnology market growth is being driven due to chronic diseases, biologics acceptance, government investment, and advanced therapies. Technological breakthroughs in genomics, proteomics, and bioinformatics are accelerating drug discovery and development. Personalized medicine and AI and machine learning are also contributing to market expansion, enhancing efficiency and addressing unmet medical needs.
Report Highlights:
Pharmaceutical and biotechnology market is accounted at USD 3.3 Tn, in 2025.
The target market size is expected to grow at a rate of USD 6.5 Tn, by 2035, and at a CAGR of 7.8%.
Depending on product, the biotechnology segment is anticipated to govern the pharmaceutical and biotechnology market share.
On the basis of age group, the adults segment is projected to rule over the pharmaceutical and biotechnology market.
According to technology, the PCR & sequencing segment is holding the upper hand in the pharmaceutical and biotechnology market.
Based on therapeutic application, the oncology segment is dominating the pharmaceutical and biotechnology market.
Stemming from end user, the pharmaceutical companies are the end user which is influencing the target market.
By region, North America is the region which is attributed to lead the pharmaceutical and biotechnology market share.
Europe is the region which has the pharmaceutical and biotechnology market growing with the highest CAGR, during the forecast period.
Key Highlights:
In May 2024, Boston Micro Fabrication (BMF) had introduced BMF Biotechnology Inc. Headquartered in San Diego, California, BMF Biotechnology Inc. which was dedicated to developing and commercialising innovative BioChips (organ-on-a-chip platforms) through cultivating large-scale tissues in vitro, helping accelerate new drug and cosmetic development.
Report Analysis:
Applications of PEGylated proteins and peptides on pharmaceutical biotechnology:
To improve solubility.
To improve thermal and mechanical stability.
To reduce immunogenicity.
To reduce renal excretion and clearance.
To protect proteins from degradation such as proteolysis.
To optimize pharmacokinetic properties such as increased blood circulation and extend plasma half - lives.
Segmentation:
By Product:
Vaccines
Cell & Gene Therapy
Others
Novartis AG
GSK plc.
Merck KGaA
AstraZeneca
Siemens Healthineers AG
Parexel International (MA) Corporation
Eli Lilly and Company
Aragen Life Sciences Ltd.
Pfizer Inc.
Johnson & Johnson Services, Inc.
Amgen Inc.
Genentech, Inc.
UCB S.A.
Sai Life Sciences Limited
What Our Report Offers:
FAQs:
Key Questions Answered in the Report.
1. What was the Pharmaceutical and Biotechnology Market size in 2025?
2. What is projected growth rate of the Pharmaceutical and Biotechnology Market during 2025-2035?
3. What are the key factors driving the Pharmaceutical and Biotechnology Market growth?
4. What are leading players in the Pharmaceutical and Biotechnology Market?
5. What are the key regions analyzed in the Pharmaceutical and Biotechnology Market?
6. Which region is dominating in the Pharmaceutical and Biotechnology Market?
The Pharmaceutical and Biotechnology Market Report offers an in-depth exploration of emerging market trends, driving factors, challenges, and key segments that shape the industry. It includes a thorough examination of regulatory frameworks, company profiles, and the latest industry developments. The report delves into product development, positioning strategies, and the impact of new technologies on the market landscape. By identifying challenges and opportunities, the report provides a detailed roadmap for market growth.
Pharmaceuticals are medicinal drugs, while biotechnology is the use of biological research to develop products from living organisms. Pharmaceuticals and biotechnology market growth is being driven due to chronic diseases, biologics acceptance, government investment, and advanced therapies. Technological breakthroughs in genomics, proteomics, and bioinformatics are accelerating drug discovery and development. Personalized medicine and AI and machine learning are also contributing to market expansion, enhancing efficiency and addressing unmet medical needs.
Report Highlights:
Pharmaceutical and biotechnology market is accounted at USD 3.3 Tn, in 2025.
The target market size is expected to grow at a rate of USD 6.5 Tn, by 2035, and at a CAGR of 7.8%.
Depending on product, the biotechnology segment is anticipated to govern the pharmaceutical and biotechnology market share.
On the basis of age group, the adults segment is projected to rule over the pharmaceutical and biotechnology market.
According to technology, the PCR & sequencing segment is holding the upper hand in the pharmaceutical and biotechnology market.
Based on therapeutic application, the oncology segment is dominating the pharmaceutical and biotechnology market.
Stemming from end user, the pharmaceutical companies are the end user which is influencing the target market.
By region, North America is the region which is attributed to lead the pharmaceutical and biotechnology market share.
Europe is the region which has the pharmaceutical and biotechnology market growing with the highest CAGR, during the forecast period.
Key Highlights:
In May 2024, Boston Micro Fabrication (BMF) had introduced BMF Biotechnology Inc. Headquartered in San Diego, California, BMF Biotechnology Inc. which was dedicated to developing and commercialising innovative BioChips (organ-on-a-chip platforms) through cultivating large-scale tissues in vitro, helping accelerate new drug and cosmetic development.
Report Analysis:
Applications of PEGylated proteins and peptides on pharmaceutical biotechnology:
To improve solubility.
To improve thermal and mechanical stability.
To reduce immunogenicity.
To reduce renal excretion and clearance.
To protect proteins from degradation such as proteolysis.
To optimize pharmacokinetic properties such as increased blood circulation and extend plasma half - lives.
Segmentation:
By Product:
- Biotechnology
- Instrument
- Consumables
- Pharmaceutical
- Biologics & Biosimilars (Large Molecules)
Vaccines
Cell & Gene Therapy
Others
- Conventional Drugs (Small Molecules)
- Children & Adolescents
- Adults
- Geriatric
- Nanotechnology
- Tissue Engineering & Regeneration
- PCR & Sequencing
- Artificial Intelligence (AI)
- Personalized Medicine
- Others
- Oncology
- Inflammatory and Infectious Diseases
- Autoimmune Disorders
- Metabolic Disorders
- Hormonal Disorders
- Disease Prevention
- Cardiovascular Diseases
- Neurological Diseases
- Others
- Pharmaceutical Companies
- Biotechnology Companies
- Healthcare Providers
- Research and Government Institutes,
- Others
- North America
- U.S.
- Canada
- Europe
- Germany
- U.K.
- France
- Russia
- Italy
- Spain
- Netherlands
- Rest of Europe
- Asia Pacific
- China
- India
- Japan
- Australia
- Indonesia
- Malaysia
- South Korea
- Rest of Asia Pacific
- Latin America
- Brazil
- Mexico
- Argentina
- Rest of Latin America
- Middle East & Africa
- GCC
- Israel
- South Africa
- Rest of Middle East & Africa
Novartis AG
GSK plc.
Merck KGaA
AstraZeneca
Siemens Healthineers AG
Parexel International (MA) Corporation
Eli Lilly and Company
Aragen Life Sciences Ltd.
Pfizer Inc.
Johnson & Johnson Services, Inc.
Amgen Inc.
Genentech, Inc.
UCB S.A.
Sai Life Sciences Limited
What Our Report Offers:
- Regional & Country-Specific Market Intelligence: Gain a competitive edge with in-depth market share breakdowns across critical regions and nations, helping you identify growth opportunities and strategic positioning.
- Strategic Entry Support for New Entrants: Expert-backed recommendations to navigate market entry challenges, establish a strong presence, and accelerate growth in unfamiliar markets.
- Accurate Long-Term Market Projections: Trusted forecasts spanning 2025 to 2035, including key milestones for 2025, 2026, and 2030, empowering data-driven decision-making for sustainable investments.
- Comprehensive Market Trend Analysis: A deep dive into market drivers, barriers, emerging opportunities, and potential risks, alongside insights into high-growth investment areas and industry challenges.
- Actionable Business Strategies: Data-powered recommendations customized for key market segments, supported by rigorous market assessments to maximize profitability.
- Competitive Landscape Mapping: Uncover prevailing industry trends, competitor tactics, and untapped opportunities to refine your market approach and stay ahead.
- Exclusive Company Profiles: Detailed evaluations of leading market players, covering business models, financial health, strategic moves, and recent advancements.
- Next-Gen Supply Chain Trends: Cutting-edge insights into technological innovations revolutionizing supply chain operations, enhancing efficiency, and reducing costs.
FAQs:
Key Questions Answered in the Report.
1. What was the Pharmaceutical and Biotechnology Market size in 2025?
2. What is projected growth rate of the Pharmaceutical and Biotechnology Market during 2025-2035?
3. What are the key factors driving the Pharmaceutical and Biotechnology Market growth?
4. What are leading players in the Pharmaceutical and Biotechnology Market?
5. What are the key regions analyzed in the Pharmaceutical and Biotechnology Market?
6. Which region is dominating in the Pharmaceutical and Biotechnology Market?
Table of Contents
181 Pages
- Global Pharmaceutical And Biotechnology Table of Contents
- Research Objective and Assumption
- Research Objectives
- Assumptions
- Abbreviations
- Market Preview
- Report Description
- Market Definition and Scope
- Executive Summary
- Market Snippet, By Product
- Market Snippet, By Age Group
- Market Snippet, By Technology
- Market Snippet, By Therapeutic Application
- Market Snippet, By End User
- Market Snippet, By Region
- Opportunity Map Analysis
- Market Dynamics, Regulations, and Trends Analysis
- Market Dynamics
- Drivers
- Restraints
- Market Opportunities
- Market Trends
- Product Launch
- Merger and Acquisitions
- Impact Analysis
- PEST Analysis
- Porter’s Analysis
- Evaluation of Early Stage R&D Projects
- Product Launch
- Collaboration and Partnership Scenarios
- Market Segmentation, By Product, Forecast Period up to 10 Years, (USD Tn)
- Overview
- Market Value and Forecast (USD Tn), and Share Analysis (%), Forecast Period up to 10 Years
- Y-o-Y Growth Analysis (%), Forecast Period up to 10 Years
- Segment Trends
- Biotechnology
- Overview
- Market Size and Forecast (USD Tn), and Y-o-Y Growth (%), Forecast Period up to 10 Years
- Instrument
- Consumables
- Pharmaceutical
- Overview
- Market Size and Forecast (USD Tn), and Y-o-Y Growth (%), Forecast Period up to 10 Years
- Biologics & Biosimilars (Large Molecules)
- Monoclonal Antibodies
- Vaccines
- Cell & Gene Therapy
- Others
- Conventional Drugs (Small Molecules)
- Market Segmentation, By Age Group, Forecast Period up to 10 Years, (USD Tn)
- Overview
- Market Value and Forecast (USD Tn), and Share Analysis (%), Forecast Period up to 10 Years
- Y-o-Y Growth Analysis (%), Forecast Period up to 10 Years
- Segment Trends
- Children & Adolescents
- Overview
- Market Size and Forecast (USD Tn), and Y-o-Y Growth (%), Forecast Period up to 10 Years
- Adults
- Overview
- Market Size and Forecast (USD Tn), and Y-o-Y Growth (%), Forecast Period up to 10 Years
- Geriatric
- Overview
- Market Size and Forecast (USD Tn), and Y-o-Y Growth (%), Forecast Period up to 10 Years
- Market Segmentation, By Technology, Forecast Period up to 10 Years, (USD Tn)
- Overview
- Market Value and Forecast (USD Tn), and Share Analysis (%), Forecast Period up to 10 Years
- Y-o-Y Growth Analysis (%), Forecast Period up to 10 Years
- Segment Trends
- Nanotechnology
- Overview
- Market Size and Forecast (USD Tn), and Y-o-Y Growth (%), Forecast Period up to 10 Years
- Tissue Engineering & Regeneration
- Overview
- Market Size and Forecast (USD Tn), and Y-o-Y Growth (%), Forecast Period up to 10 Years
- PCR & Sequencing
- Overview
- Market Size and Forecast (USD Tn), and Y-o-Y Growth (%), Forecast Period up to 10 Years
- Artificial Intelligence (AI)
- Overview
- Market Size and Forecast (USD Tn), and Y-o-Y Growth (%), Forecast Period up to 10 Years
- Personalized Medicine
- Overview
- Market Size and Forecast (USD Tn), and Y-o-Y Growth (%), Forecast Period up to 10 Years
- Others
- Overview
- Market Size and Forecast (USD Tn), and Y-o-Y Growth (%), Forecast Period up to 10 Years
- Market Segmentation, By Therapeutic Application, Forecast Period up to 10 Years, (USD Tn)
- Overview
- Market Value and Forecast (USD Tn), and Share Analysis (%), Forecast Period up to 10 Years
- Y-o-Y Growth Analysis (%), Forecast Period up to 10 Years
- Segment Trends
- Oncology
- Overview
- Market Size and Forecast (USD Tn), and Y-o-Y Growth (%), Forecast Period up to 10 Years
- Inflammatory and Infectious Diseases
- Overview
- Market Size and Forecast (USD Tn), and Y-o-Y Growth (%), Forecast Period up to 10 Years
- Autoimmune Disorders
- Overview
- Market Size and Forecast (USD Tn), and Y-o-Y Growth (%), Forecast Period up to 10 Years
- Metabolic Disorders
- Overview
- Market Size and Forecast (USD Tn), and Y-o-Y Growth (%), Forecast Period up to 10 Years
- Hormonal Disorders
- Overview
- Market Size and Forecast (USD Tn), and Y-o-Y Growth (%), Forecast Period up to 10 Years
- Disease Prevention
- Overview
- Market Size and Forecast (USD Tn), and Y-o-Y Growth (%), Forecast Period up to 10 Years
- Cardiovascular Diseases
- Overview
- Market Size and Forecast (USD Tn), and Y-o-Y Growth (%), Forecast Period up to 10 Years
- Neurological Diseases
- Overview
- Market Size and Forecast (USD Tn), and Y-o-Y Growth (%), Forecast Period up to 10 Years
- Others
- Overview
- Market Size and Forecast (USD Tn), and Y-o-Y Growth (%), Forecast Period up to 10 Years
- Market Segmentation, By End User, Forecast Period up to 10 Years, (USD Tn)
- Overview
- Market Value and Forecast (USD Tn), and Share Analysis (%), Forecast Period up to 10 Years
- Y-o-Y Growth Analysis (%), Forecast Period up to 10 Years
- Segment Trends
- Pharmaceutical Companies
- Overview
- Market Size and Forecast (USD Tn), and Y-o-Y Growth (%), Forecast Period up to 10 Years
- Biotechnology Companies
- Overview
- Market Size and Forecast (USD Tn), and Y-o-Y Growth (%), Forecast Period up to 10 Years
- Healthcare Providers
- Overview
- Market Size and Forecast (USD Tn), and Y-o-Y Growth (%), Forecast Period up to 10 Years
- Research and Government Institutes
- Overview
- Market Size and Forecast (USD Tn), and Y-o-Y Growth (%), Forecast Period up to 10 Years
- Others
- Overview
- Market Size and Forecast (USD Tn), and Y-o-Y Growth (%), Forecast Period up to 10 Years
- Market Segmentation, By Region, Forecast Period up to 10 Years, (USD Tn)
- Overview
- Market Value and Forecast (USD Tn), and Share Analysis (%), Forecast Period up to 10 Years
- Y-o-Y Growth Analysis (%), Forecast Period up to 10 Years
- Regional Trends
- North America
- Market Size and Forecast (USD Tn), By Product, Forecast Period up to 10 Years
- Market Size and Forecast (USD Tn), By Age Group, Forecast Period up to 10 Years
- Market Size and Forecast (USD Tn), By Technology, Forecast Period up to 10 Years
- Market Size and Forecast (USD Tn), By Therapeutic Application, Forecast Period up to 10 Years
- Market Size and Forecast (USD Tn), By End User, Forecast Period up to 10 Years
- Market Size and Forecast (USD Tn), By Country, Forecast Period up to 10 Years
- U.S
- Canada
- Asia Pacific
- Market Size and Forecast (USD Tn), By Product, Forecast Period up to 10 Years
- Market Size and Forecast (USD Tn), By Age Group, Forecast Period up to 10 Years
- Market Size and Forecast (USD Tn), By Technology, Forecast Period up to 10 Years
- Market Size and Forecast (USD Tn), By Therapeutic Application, Forecast Period up to 10 Years
- Market Size and Forecast (USD Tn), By End User, Forecast Period up to 10 Years
- Market Size and Forecast (USD Tn), By Country, Forecast Period up to 10 Years
- China
- India
- Japan
- Australia
- Indonesia
- Malaysia
- South Korea
- Rest of Asia Pacific
- Europe
- Market Size and Forecast (USD Tn), By Product, Forecast Period up to 10 Years
- Market Size and Forecast (USD Tn), By Age Group, Forecast Period up to 10 Years
- Market Size and Forecast (USD Tn), By Technology, Forecast Period up to 10 Years
- Market Size and Forecast (USD Tn), By Therapeutic Application, Forecast Period up to 10 Years
- Market Size and Forecast (USD Tn), By End User, Forecast Period up to 10 Years
- Market Size and Forecast (USD Tn), By Country, Forecast Period up to 10 Years
- Germany
- U.K.
- France
- Russia
- Italy
- Spain
- Netherlands
- Rest of Europe
- Latin America
- Market Size and Forecast (USD Tn), By Product, Forecast Period up to 10 Years
- Market Size and Forecast (USD Tn), By Age Group, Forecast Period up to 10 Years
- Market Size and Forecast (USD Tn), By Technology, Forecast Period up to 10 Years
- Market Size and Forecast (USD Tn), By Therapeutic Application, Forecast Period up to 10 Years
- Market Size and Forecast (USD Tn), By End User, Forecast Period up to 10 Years
- Market Size and Forecast (USD Tn), By Country, Forecast Period up to 10 Years
- Brazil
- Mexico
- Argentina
- Rest of Latin America
- Middle East & Africa
- Market Size and Forecast (USD Tn), By Product, Forecast Period up to 10 Years
- Market Size and Forecast (USD Tn), By Age Group, Forecast Period up to 10 Years
- Market Size and Forecast (USD Tn), By Technology, Forecast Period up to 10 Years
- Market Size and Forecast (USD Tn), By Therapeutic Application, Forecast Period up to 10 Years
- Market Size and Forecast (USD Tn), By End User, Forecast Period up to 10 Years
- Market Size and Forecast (USD Tn), By Country, Forecast Period up to 10 Years
- GCC
- Israel
- South Africa
- Rest of Middle East & Africa
Pricing
Currency Rates
Questions or Comments?
Our team has the ability to search within reports to verify it suits your needs. We can also help maximize your budget by finding sections of reports you can purchase.
